Weight Gain Common in Young Women After Breast Reduction Surgery
By Lori Solomon HealthDay Reporter
THURSDAY, Feb. 6, 2025 -- Many young women gain weight in the years after breast reduction surgery, according to a study published online in the February issue of Plastic and Reconstructive Surgery.
William N. Doyle Jr., from the University of South Florida Morsani College of Medicine in Tampa, and colleagues examined change in weight and body mass index (BMI) in adolescent women (aged younger than 21 years) following reduction mammaplasty. The analysis included 56 patients with weight measurements during a median 46.0 months of follow-up.
The researchers found that only 22 patients (39.3 percent) experienced a decrease in BMI at final follow-up compared with baseline. At two-, three-, and five-year visits and at final postoperative follow-up visits, patients classified as having a healthy weight preoperatively (BMI, 18.5 to 24.9 kg/m2) experienced a significant increase in BMI versus baseline. In contrast, patients classified as having overweight (BMI, 25.0 to 29.99 kg/m2) or obesity (≥30 kg/m2) did not experience significant BMI change at final postoperative follow-up.
"BMI and weight trended upward postoperatively regardless of BMI classification," the authors write. "Reduction mammaplasty alone is not sufficient to stimulate weight loss. Healthy lifestyle changes should be encouraged to help prevent weight gain in adolescent women following reduction mammaplasty."
One author disclosed receiving royalties for textbook authorship from Thieme Publishing.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Presurgical Immunotherapy Offers Long-Term Benefit in Melanoma
FRIDAY, July 18, 2025 -- Neoadjuvant systemic treatment (NST) followed by adjuvant treatment with nivolumab and relatlimab offers long-term benefit in adults with stage III/IV...
Long-Term Obesity Linked to Expression of Aging Biomarkers
THURSDAY, July 17, 2025 -- Long-term obesity is associated with the expression of biomarkers denoting antagonistic and integrative aging hallmarks in adults aged 28 to 31 years...
ENDO: Older Age, Female Sex Tied to Greater Muscle Loss With Semaglutide
THURSDAY, July 17, 2025 -- Older age and female sex may be associated with greater muscle loss in adults with obesity prescribed semaglutide, and greater muscle loss is...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.